COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs.
about
Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intoleranceThe cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risksAnti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema.New agents for the medical treatment of interstitial cystitis.Crystal and molecular structure of beta-cyclodextrins functionalized with the anti-inflammatory drug Etodolac.Chronic infection during placental malaria is associated with up-regulation of cycloxygenase-2.Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null miceDermatologic agents during pregnancy and lactation: an update and clinical review.PGE(2) -EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB.Rofecoxib versus ibuprofen for acute treatment of migraine: a randomised placebo controlled trialChemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.Synthesis and chemical and biological comparison of nitroxyl- and nitric oxide-releasing diazeniumdiolate-based aspirin derivativesThe transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts.The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway.Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line.Isolation of Bioactive Compounds That Relate to the Anti-Platelet Activity of Cymbopogon ambiguus.Cytokine expression before and after aspirin desensitization therapy in aspirin-exacerbated respiratory disease.[Current post-marketing information. Effects and adverse effects of celecoxib].COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.Parecoxib sodium, an injectable COX-2-specific inhibitor, does not affect unfractionated heparin-regulated blood coagulation parameters.Pharmacokinetics of firocoxib after intravenous administration of multiple consecutive doses in neonatal foals.Pharmacokinetics and safety of firocoxib after oral administration of repeated consecutive doses to neonatal foals.Celecoxib, a selective cyclooxygenase-2 inhibitor, attenuates renal injury in a rat model of Cisplatin-induced nephrotoxicity.Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion.Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited.Electro-acupuncture efficacy on pain control after mandibular third molar surgery.Evidence for interleukin-10-mediated inhibition of cyclo- oxygenase-2 expression and prostaglandin production in preterm human placenta.
P2860
Q28174829-665EFDF3-6EEC-4439-848C-156276D6647CQ28193254-4166E267-866A-4EBA-9994-EA0BB7ABACD6Q29346992-2BF96BE5-DC6D-483B-95D5-8B1CBEF7662DQ32066343-56FE4C58-16F4-45C2-82F7-8984958344B9Q33430067-27569E60-C2F5-4160-B8F7-104C9E34E0D1Q33702586-A291C4D7-1509-4CEF-AC9A-9E603E15C21CQ33808556-F2658568-8E2B-4042-9D29-037A95E1A3AEQ34657443-DCEC5849-8DAB-4B37-BE58-B9BCA626367CQ35130538-957BAA50-BAA8-474D-9AAF-FB0CC32B0C67Q35520722-4332BD99-6B9F-4DAB-8A00-25251984AA53Q35638851-98BB0410-A760-4232-99AA-0C84DA89D0ECQ37432633-3D2EF47A-1209-4B6C-980A-79E8B05F036DQ38297445-13A2D49F-1853-4D23-AD2C-0E55EA78878FQ39489252-F5C60ADD-B40A-4D57-8C74-53DF073F411EQ40733087-A22BE0F9-5919-4866-87B0-CE65D2F68867Q42802611-83F66734-97FA-4603-A53E-A4F2C9E44CA6Q43738554-D18A056E-006E-41E3-B916-381AF86F8566Q43971857-92D2B1D9-721B-4E6B-A60C-551AC64562CAQ44813874-1E5875F1-6F4F-4410-9B55-C3AB57F06E1FQ44854805-9151A058-16DA-4A50-8EE6-2379596F319DQ44872010-CDA9FF82-55E1-4237-AA51-B008A63DB559Q44997040-6E7E59B2-A456-4EEE-A552-3D2ACEBD3162Q46322235-EC58B534-B6C7-45F8-B377-FD53CBFC5D9FQ46644169-A0F42AEF-BA4C-4E23-8A45-AC1D14709B32Q47372560-6228700F-06E9-43C5-879B-7209D3A8F301Q48550328-70CAEA11-3017-42F3-8FCF-D6A7441536EEQ54626257-4A7C2B02-AD40-44C6-92FB-70F052478F73
P2860
COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
COX-2-Specific inhibitors--the ...... c and anti-inflammatory drugs.
@ast
COX-2-Specific inhibitors--the ...... c and anti-inflammatory drugs.
@en
COX-2-Specific inhibitors--the ...... c and anti-inflammatory drugs.
@nl
type
label
COX-2-Specific inhibitors--the ...... c and anti-inflammatory drugs.
@ast
COX-2-Specific inhibitors--the ...... c and anti-inflammatory drugs.
@en
COX-2-Specific inhibitors--the ...... c and anti-inflammatory drugs.
@nl
prefLabel
COX-2-Specific inhibitors--the ...... c and anti-inflammatory drugs.
@ast
COX-2-Specific inhibitors--the ...... c and anti-inflammatory drugs.
@en
COX-2-Specific inhibitors--the ...... c and anti-inflammatory drugs.
@nl
P2093
P356
P1476
COX-2-Specific inhibitors--the ...... c and anti-inflammatory drugs.
@en
P2093
P304
P356
10.1007/S100670070024
P577
2000-01-01T00:00:00Z